← Evidence map

ArticleJTO clinical and research reports2024

RELAY, Erlotinib Plus Ramucirumab in Untreated,

Kazumi Nishino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

4 papers cite it

2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 38304857